Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Elevance (ELV) PT Raised to $571 at Jefferies
October 20, 2022 8:48 AM EDTJefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.
The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More
